Pub Date : 2022-09-30DOI: 10.57125/fem.2022.09.30.01
Background: Primary care and mental health services for pregnant and postpartum moms are facing increased difficulties as a result of the war in Ukraine. Objective: To review and identify the available literature and conduct a study in order to determine psychological rehabilitation adaptation of pregnant women and mothers in the postpartum period who experienced traumatic events during the war in Ukraine Methodology: In order to assess the effects of this condition, data was gathered. The existence of risk factors, such as a change in lifestyle associated with being a refugee and rehabilitation, is the most important factor associated with PSTD in pregnant and postpartum moms. Results: Observational studies suggest that the symptoms of PSTD may be improved by coping self-efficacy therapies. Conclusion: Further study is required to examine these components in greater detail and to suggest additional rehabilitation strategies.
{"title":"Psycho-rehabilitation adaptation of pregnant women and mothers in the postpartum period who experienced traumatic events during the war","authors":"","doi":"10.57125/fem.2022.09.30.01","DOIUrl":"https://doi.org/10.57125/fem.2022.09.30.01","url":null,"abstract":"Background: Primary care and mental health services for pregnant and postpartum moms are facing increased difficulties as a result of the war in Ukraine.\u0000\u0000Objective: To review and identify the available literature and conduct a study in order to determine psychological rehabilitation adaptation of pregnant women and mothers in the postpartum period who experienced traumatic events during the war in Ukraine\u0000\u0000Methodology: In order to assess the effects of this condition, data was gathered. The existence of risk factors, such as a change in lifestyle associated with being a refugee and rehabilitation, is the most important factor associated with PSTD in pregnant and postpartum moms.\u0000\u0000Results: Observational studies suggest that the symptoms of PSTD may be improved by coping self-efficacy therapies.\u0000\u0000Conclusion: Further study is required to examine these components in greater detail and to suggest additional rehabilitation strategies.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117247828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-30DOI: 10.57125/fem.2022.09.30.05
Olha Тatarina
Aims: There is a tangible informative lack in terms of medical innovation in Ukraine. Little accessible information regarding the steps being taken to foster medical innovation in Ukraine is due to the country's ongoing conflict and the significant pressure on its healthcare sector. Such an informative gap emphasises the necessity for additional research into Ukraine's unique medical landscape. Study design: Literature review Methodology: MEDLINE, Cochrane Reviews, and Pedro were among the databases used to conduct the literature search. The conjunctions "AND" and "OR" were used with certain keywords. The articles' time range was restricted between 2018 and 2022 in order to evaluate only present recent facts. Papers discussing innovative medicine, their development, distribution or procurement were included in the inclusion criteria. Results: Most studies examined how could be achieved the access to revolutionary medicine ignoring the medicine development. The creation of innovative medications was the subject of just one study. Most of the research discussed HTA and MEA and how important they were to ensuring patients had easy access to cutting-edge medications. Legislative or economic restrictions were the only one’s present. Conclusion: It is unclear how innovative pharmaceutical development is currently progressing in Ukraine. Health Technology Assessment (HTA) and Managed Entry Agreements (MEA) are being used to improve the access to innovative medicine in Ukraine. Buying medications for chronic illnesses is simple and convenient. In order to develop and distribute new medicine in Ukraine, regulatory and economic restrictions must be removed. Scientific Novelty: This study is the first to analyse the availability or development of innovative medication, therefore it can serve as the foundation for future studies by other groups. However, it would necessitate further on-the-ground research concerning the actual situation surrounding the creation, dissemination, and acquisition of innovative medicines. The ongoing war effort may hinder this.
{"title":"Innovations in Ukrainian medicine: priorities, directions, and forecasts","authors":"Olha Тatarina","doi":"10.57125/fem.2022.09.30.05","DOIUrl":"https://doi.org/10.57125/fem.2022.09.30.05","url":null,"abstract":"Aims: There is a tangible informative lack in terms of medical innovation in Ukraine. Little accessible information regarding the steps being taken to foster medical innovation in Ukraine is due to the country's ongoing conflict and the significant pressure on its healthcare sector. Such an informative gap emphasises the necessity for additional research into Ukraine's unique medical landscape.\u0000\u0000Study design: Literature review\u0000\u0000Methodology: MEDLINE, Cochrane Reviews, and Pedro were among the databases used to conduct the literature search. The conjunctions \"AND\" and \"OR\" were used with certain keywords. The articles' time range was restricted between 2018 and 2022 in order to evaluate only present recent facts. Papers discussing innovative medicine, their development, distribution or procurement were included in the inclusion criteria.\u0000\u0000Results: Most studies examined how could be achieved the access to revolutionary medicine ignoring the medicine development. The creation of innovative medications was the subject of just one study. Most of the research discussed HTA and MEA and how important they were to ensuring patients had easy access to cutting-edge medications. Legislative or economic restrictions were the only one’s present.\u0000\u0000Conclusion: It is unclear how innovative pharmaceutical development is currently progressing in Ukraine. Health Technology Assessment (HTA) and Managed Entry Agreements (MEA) are being used to improve the access to innovative medicine in Ukraine. Buying medications for chronic illnesses is simple and convenient. In order to develop and distribute new medicine in Ukraine, regulatory and economic restrictions must be removed.\u0000\u0000Scientific Novelty: This study is the first to analyse the availability or development of innovative medication, therefore it can serve as the foundation for future studies by other groups. However, it would necessitate further on-the-ground research concerning the actual situation surrounding the creation, dissemination, and acquisition of innovative medicines. The ongoing war effort may hinder this.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"247 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134403631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-30DOI: 10.57125/fem.2022.09.30.03
Aims: This narrative review's main objectives are to give the idea thorough COVID-19 and neurological diseases overview as well as to request a significant attention to important research areas that are closely related to the topic. Methodology: "Coronavirus SARS/ COVID-19/ SARS-CoV-2," "neurology," "mechanism," "neuroinvasion," "neuron damage," "myopathy," "neuromuscular," "central nervous system," and "CNS" were used to search Medline, PubMed, and Google Scholar. Results: highlights a number of significant findings, some of which consist of the detection of SARS-CoV-2 genome RNA in the cerebrospinal fluid, a probability for immediate infection of the central nervous system, penetrating to the brain's cortex via the olfactory nerve, as well as the implication of the peripheral nervous system in neurological disorders that are associated with COVID-19. Pakistani studies that found substantial neurological adverse responses in 23% of COVID-19 participants, the most prevalent from them were headaches and insomnia. Scientific Novelty: Provide a deep overview of previous researches in order to find the link between COVID-19 and neurological diseases. Conclusion: The link between COVID-19 and nervous system symptoms development during the pandemic is supported by neurological manifestations, which in accordance with studies are addressing the cerebral involvement of SARS-CoV and MERS-CoV. It is probable that the presence of neurological disorders in COVID-19 instances may increase the probability of patients with symptoms connected to neuroscience receiving an inaccurate diagnosis. These neurological issues that have been reported highlight how vital it is to realise the link between the SARS-CoV-2 infection and neurological impairments, as well as its association with the severity of the disease and death. Healthcare establishments should educate customers about COVID-19's neurological issues and report adverse events. Media can spread these messages. Governments can support research to find methods of treatment, and trade systems can import foreign pharmaceuticals for best results.
{"title":"The correlation between risk factors of COVID-19 and nervous system damage: Pakistan based Analysis","authors":"","doi":"10.57125/fem.2022.09.30.03","DOIUrl":"https://doi.org/10.57125/fem.2022.09.30.03","url":null,"abstract":"Aims: This narrative review's main objectives are to give the idea thorough COVID-19 and neurological diseases overview as well as to request a significant attention to important research areas that are closely related to the topic.\u0000\u0000Methodology: \"Coronavirus SARS/ COVID-19/ SARS-CoV-2,\" \"neurology,\" \"mechanism,\" \"neuroinvasion,\" \"neuron damage,\" \"myopathy,\" \"neuromuscular,\" \"central nervous system,\" and \"CNS\" were used to search Medline, PubMed, and Google Scholar.\u0000\u0000Results: highlights a number of significant findings, some of which consist of the detection of SARS-CoV-2 genome RNA in the cerebrospinal fluid, a probability for immediate infection of the central nervous system, penetrating to the brain's cortex via the olfactory nerve, as well as the implication of the peripheral nervous system in neurological disorders that are associated with COVID-19. Pakistani studies that found substantial neurological adverse responses in 23% of COVID-19 participants, the most prevalent from them were headaches and insomnia.\u0000\u0000Scientific Novelty: Provide a deep overview of previous researches in order to find the link between COVID-19 and neurological diseases.\u0000\u0000Conclusion: The link between COVID-19 and nervous system symptoms development during the pandemic is supported by neurological manifestations, which in accordance with studies are addressing the cerebral involvement of SARS-CoV and MERS-CoV. It is probable that the presence of neurological disorders in COVID-19 instances may increase the probability of patients with symptoms connected to neuroscience receiving an inaccurate diagnosis. These neurological issues that have been reported highlight how vital it is to realise the link between the SARS-CoV-2 infection and neurological impairments, as well as its association with the severity of the disease and death. Healthcare establishments should educate customers about COVID-19's neurological issues and report adverse events. Media can spread these messages. Governments can support research to find methods of treatment, and trade systems can import foreign pharmaceuticals for best results.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129878800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-30DOI: 10.57125/fem.2022.06.30.01
Anatolija Krasnova
Background: Global vaccination programs against the coronavirus illness of 2019 (COVID-19) have been established as the primary measure to minimise and control the effects of the COVID-19 pandemic. During pregnancy, it is assumed that the expectant mother and her fetus are both in danger from the possibility of a viral infection. Aim: to evaluate the safety and effectiveness of vaccination against COVID-19 for pregnant women and determine the impact of vaccination on pregnancy outcomes. Methods: In this review, English studies from common databases such as Pubmed/MEDLINE, Web of Science, Scopus, and the Cochrane Library with the keywords "Vaccination," "pregnancy," and "pregnant women," combined with keywords, involving "COVID-19," were involved. The end date for this review is March 2022. Scientific novelty: The main objective of this paper is to evaluate the effect of vaccination of pregnant women against COVID-19. Even though many studies assessed the efficacy of vaccination against COVID-19, most failed to determine the safety and effectiveness of COVID-19 vaccination for immunocompromised patients, especially pregnant women. Additionally, the impact of COVID-19 vaccination on neonatal outcomes was evaluated. The practical significance of the obtained result: Concerns have also been raised about potential risks associated with vaccination during pregnancy or breastfeeding. Given these uncertainties, it is important for healthcare providers to carefully consider the risks and benefits of COVID-19 vaccination for pregnant women and their babies. Further research is needed to better understand the effects of vaccination on perinatal outcomes and to inform clinical decision-making around vaccine use in this population. Conclusion: The COVID-19 vaccination is a safe and effective way to protect pregnant women from the virus. The benefits of getting vaccinated outweigh the risks, as pregnant women are at an increased risk of severe illness and complications from COVID-19. The Centers for Disease Control and Prevention (CDC) recommends that pregnant women get vaccinated, and many healthcare providers also recommend it. However, it is important for pregnant women to discuss their individual situation with their healthcare provider before making a decision about vaccination. Overall, getting vaccinated can help to protect both the mother and her unborn child from COVID-19. Background: Global vaccination programs against the coronavirus illness of 2019 (COVID-19) have been established as the primary measure to minimise and control the effects of the COVID-19 pandemic. During pregnancy, it is assumed that the expectant mother and her fetus are both in danger from the possibility of a viral infection. Aim: to evaluate the safety and effectiveness of vaccination against COVID-19 for pregnant women and determine the impact of vaccination on pregnancy outcomes. Methods: In this review, English studies from common databases such as Pubmed/MEDLINE, W
背景:针对2019年冠状病毒病(COVID-19)的全球疫苗接种规划已被确立为最大限度地减少和控制COVID-19大流行影响的主要措施。在怀孕期间，孕妇和胎儿都有可能受到病毒感染。目的:评价孕妇接种COVID-19疫苗的安全性和有效性，并确定疫苗接种对妊娠结局的影响。方法:本综述纳入Pubmed/MEDLINE、Web of Science、Scopus和Cochrane Library等常用数据库中以“疫苗接种”、“妊娠”和“孕妇”为关键词并结合“COVID-19”相关关键词的英文研究。本次审查的结束日期是2022年3月。新颖性:本文的主要目的是评估孕妇接种COVID-19疫苗的效果。尽管许多研究评估了COVID-19疫苗接种的有效性，但大多数研究未能确定免疫功能低下患者(特别是孕妇)接种COVID-19疫苗的安全性和有效性。此外，还评估了COVID-19疫苗接种对新生儿结局的影响。所获得结果的实际意义:人们还对怀孕或哺乳期间接种疫苗的潜在风险表示担忧。鉴于这些不确定性，医疗保健提供者必须仔细考虑孕妇及其婴儿接种COVID-19疫苗的风险和益处。需要进一步的研究来更好地了解疫苗接种对围产期结局的影响，并为在这一人群中使用疫苗的临床决策提供信息。结论:接种新冠肺炎疫苗是一种安全有效的保护孕妇免受病毒感染的方法。接种疫苗的好处大于风险，因为孕妇患COVID-19严重疾病和并发症的风险增加。疾病控制和预防中心(CDC)建议孕妇接种疫苗，许多医疗服务提供者也建议接种疫苗。然而，在决定是否接种疫苗之前，孕妇与医疗保健提供者讨论他们的个人情况是很重要的。总的来说，接种疫苗有助于保护母亲和未出生的孩子免受COVID-19的感染。背景:针对2019年冠状病毒病(COVID-19)的全球疫苗接种规划已被确立为最大限度地减少和控制COVID-19大流行影响的主要措施。在怀孕期间，孕妇和胎儿都有可能受到病毒感染。目的:评价孕妇接种COVID-19疫苗的安全性和有效性，并确定疫苗接种对妊娠结局的影响。方法:本综述纳入Pubmed/MEDLINE、Web of Science、Scopus和Cochrane Library等常用数据库中以“疫苗接种”、“妊娠”和“孕妇”为关键词并结合“COVID-19”相关关键词的英文研究。本次审查的结束日期是2022年3月。新颖性:本文的主要目的是评估孕妇接种COVID-19疫苗的效果。尽管许多研究评估了COVID-19疫苗接种的有效性，但大多数研究未能确定免疫功能低下患者(特别是孕妇)接种COVID-19疫苗的安全性和有效性。此外，还评估了COVID-19疫苗接种对新生儿结局的影响。所获得结果的实际意义:人们还对怀孕或哺乳期间接种疫苗的潜在风险表示担忧。鉴于这些不确定性，医疗保健提供者必须仔细考虑孕妇及其婴儿接种COVID-19疫苗的风险和益处。需要进一步的研究来更好地了解疫苗接种对围产期结局的影响，并为在这一人群中使用疫苗的临床决策提供信息。结论:接种新冠肺炎疫苗是一种安全有效的保护孕妇免受病毒感染的方法。接种疫苗的好处大于风险，因为孕妇患COVID-19严重疾病和并发症的风险增加。疾病控制和预防中心(CDC)建议孕妇接种疫苗，许多医疗服务提供者也建议接种疫苗。然而，在决定是否接种疫苗之前，孕妇与医疗保健提供者讨论他们的个人情况是很重要的。总的来说，接种疫苗有助于保护母亲和未出生的孩子免受COVID-19的感染。
{"title":"Vaccination of pregnant women against COVID-19 under martial law: a narrative review","authors":"Anatolija Krasnova","doi":"10.57125/fem.2022.06.30.01","DOIUrl":"https://doi.org/10.57125/fem.2022.06.30.01","url":null,"abstract":"Background: Global vaccination programs against the coronavirus illness of 2019 (COVID-19) have been established as the primary measure to minimise and control the effects of the COVID-19 pandemic. During pregnancy, it is assumed that the expectant mother and her fetus are both in danger from the possibility of a viral infection.\u0000\u0000Aim: to evaluate the safety and effectiveness of vaccination against COVID-19 for pregnant women and determine the impact of vaccination on pregnancy outcomes.\u0000\u0000Methods: In this review, English studies from common databases such as Pubmed/MEDLINE, Web of Science, Scopus, and the Cochrane Library with the keywords \"Vaccination,\" \"pregnancy,\" and \"pregnant women,\" combined with keywords, involving \"COVID-19,\" were involved. The end date for this review is March 2022.\u0000\u0000Scientific novelty: The main objective of this paper is to evaluate the effect of vaccination of pregnant women against COVID-19. Even though many studies assessed the efficacy of vaccination against COVID-19, most failed to determine the safety and effectiveness of COVID-19 vaccination for immunocompromised patients, especially pregnant women. Additionally, the impact of COVID-19 vaccination on neonatal outcomes was evaluated.\u0000\u0000The practical significance of the obtained result: Concerns have also been raised about potential risks associated with vaccination during pregnancy or breastfeeding. Given these uncertainties, it is important for healthcare providers to carefully consider the risks and benefits of COVID-19 vaccination for pregnant women and their babies. Further research is needed to better understand the effects of vaccination on perinatal outcomes and to inform clinical decision-making around vaccine use in this population.\u0000\u0000 Conclusion: The COVID-19 vaccination is a safe and effective way to protect pregnant women from the virus. The benefits of getting vaccinated outweigh the risks, as pregnant women are at an increased risk of severe illness and complications from COVID-19. The Centers for Disease Control and Prevention (CDC) recommends that pregnant women get vaccinated, and many healthcare providers also recommend it. However, it is important for pregnant women to discuss their individual situation with their healthcare provider before making a decision about vaccination. Overall, getting vaccinated can help to protect both the mother and her unborn child from COVID-19.\u0000\u0000Background: Global vaccination programs against the coronavirus illness of 2019 (COVID-19) have been established as the primary measure to minimise and control the effects of the COVID-19 pandemic. During pregnancy, it is assumed that the expectant mother and her fetus are both in danger from the possibility of a viral infection.\u0000\u0000Aim: to evaluate the safety and effectiveness of vaccination against COVID-19 for pregnant women and determine the impact of vaccination on pregnancy outcomes.\u0000\u0000Methods: In this review, English studies from common databases such as Pubmed/MEDLINE, W","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"116 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121473122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-30DOI: 10.57125/fem.2022.06.30.04
Aims: The main goal of this study is to draw attention to the dangers of anaesthetic management during laparoscopic procedures on the abdominal aorta and its branches. Methodology: In this study, the risks of anaesthetic management during laparoscopic interventions on the abdominal aorta and its branches were determined by a systematic search use. The most recent studies in Scopus, PubMed, and google scholar databases. The search terms used were: [Risk OR adverse effect OR side effects] AND [Anaesthesia OR Anaesthetic management] AND [laparoscopic intervention or laparoscopy] AND [abdominal aorta OR abdominal aortic aneurysms] were evaluated. Results: 1070 articles using electronic databases were first collected. After a deep search, 238 articles were selected and given to the writers for additional evaluations. A thorough brainstorming session that resulted in the selection of 12 relevant papers for the evaluation was conducted. Abdominal aortic aneurysms (AAAs) that is affected by age necessitate surgical treatment. For AAA patients, laparoscopic surgery has become a vital procedure with a number of advantages. Laparoscopic surgery has become a standard medical procedure because it reduces tissue trauma and provides significant advantages. The administration of anaesthesia in patients having laparoscopic surgery, however, is crucial and demands special attention. Despite the rarity of absolute contraindications, the anaesthetist must carefully choose the patients who may undergo such procedures and must constantly be prepared for intraoperative issues. The pain experienced by patients having laparoscopic operations, such as appendectomy, is likely to be understated, so small incisions do not always imply reduced pain levels. Scientific Novelty: This is the first systematic review that highlights anaesthetic management during laparoscopic interventions on the abdominal aorta and its branches risks. Conclusion: In extended laparoscopic surgery, general anaesthesia and epidural analgesia can be used together with the advantage of reduced postoperative pain severity thanks to patient-controlled spinal anaesthesia.
{"title":"Risks of anaesthetic management during laparoscopic interventions on the abdominal aorta and its branches","authors":"","doi":"10.57125/fem.2022.06.30.04","DOIUrl":"https://doi.org/10.57125/fem.2022.06.30.04","url":null,"abstract":"Aims: The main goal of this study is to draw attention to the dangers of anaesthetic management during laparoscopic procedures on the abdominal aorta and its branches.\u0000\u0000Methodology: In this study, the risks of anaesthetic management during laparoscopic interventions on the abdominal aorta and its branches were determined by a systematic search use. The most recent studies in Scopus, PubMed, and google scholar databases. The search terms used were: [Risk OR adverse effect OR side effects] AND [Anaesthesia OR Anaesthetic management] AND [laparoscopic intervention or laparoscopy] AND [abdominal aorta OR abdominal aortic aneurysms] were evaluated.\u0000\u0000Results: 1070 articles using electronic databases were first collected. After a deep search, 238 articles were selected and given to the writers for additional evaluations. A thorough brainstorming session that resulted in the selection of 12 relevant papers for the evaluation was conducted. Abdominal aortic aneurysms (AAAs) that is affected by age necessitate surgical treatment. For AAA patients, laparoscopic surgery has become a vital procedure with a number of advantages. Laparoscopic surgery has become a standard medical procedure because it reduces tissue trauma and provides significant advantages. The administration of anaesthesia in patients having laparoscopic surgery, however, is crucial and demands special attention. Despite the rarity of absolute contraindications, the anaesthetist must carefully choose the patients who may undergo such procedures and must constantly be prepared for intraoperative issues. The pain experienced by patients having laparoscopic operations, such as appendectomy, is likely to be understated, so small incisions do not always imply reduced pain levels.\u0000\u0000Scientific Novelty: This is the first systematic review that highlights anaesthetic management during laparoscopic interventions on the abdominal aorta and its branches risks.\u0000\u0000Conclusion: In extended laparoscopic surgery, general anaesthesia and epidural analgesia can be used together with the advantage of reduced postoperative pain severity thanks to patient-controlled spinal anaesthesia.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130134494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-30DOI: 10.57125/fem.2022.06.30.02
The parallel development of digital and telecommunication technologies in recent years has created ample opportunities to improve traditional healthcare delivery systems. New models of healthcare services are supported by scientific developments and digital innovations. Objectives: To improve doctors’ expertise and healthcare managers with the main achievements of digital technologies introduction in practical medicine and the possibilities for further development of technologies in this area. Methodology: A review of articles from professional peer-reviewed journals in the online medical literature search system MEDLINE from the US National Library of Medicine for 2018-2022 was conducted. The article concerns the use of digital innovations in clinical medicine, their achievements in oncology, cardiology, medical imaging and other healthcare fields. Results: The article discusses the main digital strategies that are part of the practical work of doctors and create new workflows and interactions between patients and specialists of medical institutions. Attention is paid to the advances in computer technology and the challenges they pose to the quality of medical care. The introduction of telemedicine, problems of validation of results and clinical use of artificial intelligence applications, as well as opportunities for their development in the future are discussed. Conclusion: New technologies, including artificial intelligence algorithms, machine learning, image recognition, radiomics, and telemedicine, are creating the prerequisites for the development of new forms of healthcare delivery. The combination of telemedicine, server-based applications, and machine learning algorithms can provide a synchronised solution to the challenges faced by modern society in ensuring a healthy future around the world.
{"title":"Implementation of digital technologies in the medicine of the future","authors":"","doi":"10.57125/fem.2022.06.30.02","DOIUrl":"https://doi.org/10.57125/fem.2022.06.30.02","url":null,"abstract":"The parallel development of digital and telecommunication technologies in recent years has created ample opportunities to improve traditional healthcare delivery systems. New models of healthcare services are supported by scientific developments and digital innovations.\u0000\u0000Objectives: To improve doctors’ expertise and healthcare managers with the main achievements of digital technologies introduction in practical medicine and the possibilities for further development of technologies in this area.\u0000\u0000Methodology: A review of articles from professional peer-reviewed journals in the online medical literature search system MEDLINE from the US National Library of Medicine for 2018-2022 was conducted. The article concerns the use of digital innovations in clinical medicine, their achievements in oncology, cardiology, medical imaging and other healthcare fields.\u0000\u0000Results: The article discusses the main digital strategies that are part of the practical work of doctors and create new workflows and interactions between patients and specialists of medical institutions. Attention is paid to the advances in computer technology and the challenges they pose to the quality of medical care. The introduction of telemedicine, problems of validation of results and clinical use of artificial intelligence applications, as well as opportunities for their development in the future are discussed.\u0000\u0000Conclusion: New technologies, including artificial intelligence algorithms, machine learning, image recognition, radiomics, and telemedicine, are creating the prerequisites for the development of new forms of healthcare delivery. The combination of telemedicine, server-based applications, and machine learning algorithms can provide a synchronised solution to the challenges faced by modern society in ensuring a healthy future around the world.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"121 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121262862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-30DOI: 10.57125/fem.2022.06.30.05
Aims: This article examines the condition of medicine in Pakistan utilising existing scientific articles, reports, and other published information in order to describe the position of the country regarding medication quality and the presence of deprived and/or false pharmaceutical preparations. Methodology: In this study, studies concerned with the condition of medicine in Pakistan have been systematically searched. The most sustainable recent studies on the condition of medicine in Pakistan in PubMed, Medline, the Cochrane library, EmBase, and Google Scholar were evaluated for this systematic review. The search criteria were [Medicine or drug] AND [analysis] AND [Pakistan]. To guarantee the caliber and consistency of the selected articles, many criteria were utilised for article eligibility, in accordance with the PRISMA principles and critical assessment tools. Results: The authors first retrieved 750 papers for use in electronic databases. These publications were then once again compared to the study's goals, and any that didn't fit the bill were disregarded. After further screening 40 publications were chosen and dispersed to the authors for additional evaluations. The authors' detailed brainstorming session resulted in the inclusion of 18 pertinent papers in the review. Scientific Novelty: This is the first systematic review performed in Pakistan in order to highlight the state of medicine. Conclusion: The research suggests that to effectively regulate substandard and counterfeit medication in Pakistan, regulatory procedures for facility inspections and Good Manufacturing Practices (GMP) assessments, analytical laboratories, and capacity building, all need to be strengthened. The material that is currently available cannot support the claim that 40–50% of Pakistan's medications are of low quality. The primary causes of the subpar services provided by community pharmacies include a lack of competent personnel, a lack of advice, and a lack of professionalism on the part of the dispensers, as well as the vagueness of rules and how they are applied.
{"title":"Analysis of the state of medicine in Pakistan: challenges and future prospects","authors":"","doi":"10.57125/fem.2022.06.30.05","DOIUrl":"https://doi.org/10.57125/fem.2022.06.30.05","url":null,"abstract":"Aims: This article examines the condition of medicine in Pakistan utilising existing scientific articles, reports, and other published information in order to describe the position of the country regarding medication quality and the presence of deprived and/or false pharmaceutical preparations.\u0000\u0000Methodology: In this study, studies concerned with the condition of medicine in Pakistan have been systematically searched. The most sustainable recent studies on the condition of medicine in Pakistan in PubMed, Medline, the Cochrane library, EmBase, and Google Scholar were evaluated for this systematic review. The search criteria were [Medicine or drug] AND [analysis] AND [Pakistan]. To guarantee the caliber and consistency of the selected articles, many criteria were utilised for article eligibility, in accordance with the PRISMA principles and critical assessment tools.\u0000\u0000Results: The authors first retrieved 750 papers for use in electronic databases. These publications were then once again compared to the study's goals, and any that didn't fit the bill were disregarded. After further screening 40 publications were chosen and dispersed to the authors for additional evaluations. The authors' detailed brainstorming session resulted in the inclusion of 18 pertinent papers in the review.\u0000\u0000Scientific Novelty: This is the first systematic review performed in Pakistan in order to highlight the state of medicine.\u0000\u0000Conclusion: The research suggests that to effectively regulate substandard and counterfeit medication in Pakistan, regulatory procedures for facility inspections and Good Manufacturing Practices (GMP) assessments, analytical laboratories, and capacity building, all need to be strengthened. The material that is currently available cannot support the claim that 40–50% of Pakistan's medications are of low quality. The primary causes of the subpar services provided by community pharmacies include a lack of competent personnel, a lack of advice, and a lack of professionalism on the part of the dispensers, as well as the vagueness of rules and how they are applied.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"2008 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123811462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-30DOI: 10.57125/fem.2022.06.30.03
Olha Yuryk, Olena Barabanchyk, Milan Malets
Background The improvement of healthcare services is one of the highest priorities for all societies worldwide. Healthcare services have shown vivid changes in the last decades due to technological advances, from examining patients and diagnosis to recently developed drugs. Although there are significant efforts to improve healthcare, humanity faces many challenges. Aim: to study the recent medical innovations in the different aspects of healthcare services. The authors also aim to investigate the various modern challenges in medicine. Methods: PubMed, Web of Science, Scopus, Embase, SpringerLink, and the Cochrane Library were searched in order to find various articles concerning this topic. The next search strategies were used: (medical innovations) AND (artificial intelligence) AND (medical challenges). These strategies were used for searches that ended in April 2022. Scientific novelty: Doctors used to make their own opinions in varied cases by means of limited tools. However, together with the introduction of modern technologies into the healthcare system over the previous few decades, medical practice has become increasingly dependent on technology. Medical technology is the development of instruments with the overall purpose of increasing patients' quality of life. There is much anticipation for the new tools one can create and for the outcomes they will enable, as diagnostic and treatment equipment constantly improves. Therefore, in this review, the aim is to address the tactics of the new technologies and applications in medicine. Conclusion: Medical innovations exist in all healthcare aspects, from education and diagnosis to management. Recent technologies have demonstrated a considerable benefit in healthcare services improvement. However, a number of obstacles that both societies and individuals face are illustrated. There is a growing interest in resolving current concerns and challenges and obtaining the greatest benefits from medical breakthroughs.
背景:改善卫生保健服务是全世界所有社会的最高优先事项之一。由于技术的进步，医疗保健服务在过去几十年里发生了生动的变化，从检查病人和诊断到最近开发的药物。尽管在改善医疗保健方面做出了重大努力，但人类仍面临许多挑战。目的:研究近年来在医疗保健服务的不同方面的医学创新。作者还旨在调查医学中的各种现代挑战。方法:检索PubMed、Web of Science、Scopus、Embase、SpringerLink和Cochrane Library，查找与该主题相关的各种文章。接下来使用的搜索策略是:(医疗创新)、(人工智能)和(医疗挑战)。这些策略被用于2022年4月结束的搜索。科学的新颖性:医生过去常常在各种情况下通过有限的工具发表自己的意见。然而，在过去的几十年里，随着现代技术的引入，医疗实践越来越依赖于技术。医疗技术是以提高患者生活质量为总目的的仪器的发展。随着诊断和治疗设备的不断改进，人们对可以创造的新工具以及它们将带来的结果充满了期待。因此，本文就新技术在医学上的应用策略进行综述。结论:从教育、诊断到管理，医疗创新无处不在。最近的技术已证明在改善医疗保健服务方面有相当大的好处。然而，社会和个人都面临着一些障碍。人们越来越有兴趣解决当前的关切和挑战，并从医学突破中获得最大利益。
{"title":"Innovations in medicine: modern challenges, future definitions: A narrative review","authors":"Olha Yuryk, Olena Barabanchyk, Milan Malets","doi":"10.57125/fem.2022.06.30.03","DOIUrl":"https://doi.org/10.57125/fem.2022.06.30.03","url":null,"abstract":"Background The improvement of healthcare services is one of the highest priorities for all societies worldwide. Healthcare services have shown vivid changes in the last decades due to technological advances, from examining patients and diagnosis to recently developed drugs. Although there are significant efforts to improve healthcare, humanity faces many challenges.\u0000\u0000Aim: to study the recent medical innovations in the different aspects of healthcare services. The authors also aim to investigate the various modern challenges in medicine.\u0000\u0000Methods: PubMed, Web of Science, Scopus, Embase, SpringerLink, and the Cochrane Library were searched in order to find various articles concerning this topic. The next search strategies were used: (medical innovations) AND (artificial intelligence) AND (medical challenges). These strategies were used for searches that ended in April 2022.\u0000\u0000Scientific novelty: Doctors used to make their own opinions in varied cases by means of limited tools. However, together with the introduction of modern technologies into the healthcare system over the previous few decades, medical practice has become increasingly dependent on technology. Medical technology is the development of instruments with the overall purpose of increasing patients' quality of life. There is much anticipation for the new tools one can create and for the outcomes they will enable, as diagnostic and treatment equipment constantly improves. Therefore, in this review, the aim is to address the tactics of the new technologies and applications in medicine.\u0000\u0000Conclusion: Medical innovations exist in all healthcare aspects, from education and diagnosis to management. Recent technologies have demonstrated a considerable benefit in healthcare services improvement. However, a number of obstacles that both societies and individuals face are illustrated. There is a growing interest in resolving current concerns and challenges and obtaining the greatest benefits from medical breakthroughs.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127081061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-30DOI: 10.57125/fem.2022.03.25.03
Background: Congenital heart disease (CHD) is a disorder and abnormality of the heart or the great vessels of the thorax, which usually occurs during fetal development. It has been reported that CHD is a common condition. Nearly 25% of newborns with critical types of CHD require surgical intervention in the first year of life. Hence, increasing numbers of the annually conducted cardiopulmonary bypass (CPB) cardiac surgeries are usually associated with postoperative bleeding and coagulopathy. Bleeding after CPB usually requires a replacement therapy, including the transfusion of whole blood, red blood cells, coagulation factors, or platelets. Aim: to identify the pathophysiology of coagulopathy following cardiac surgery, how it impacts the clinical outcomes, and the available management options. Methods: In this review, we only included English articles from common electronic databases such as PubMed /MEDLINE, Web of Science, Scopus, and the Cochrane Library with the keywords "congenital heart disease", "cardiac surgery" combined with keywords involving "coagulopathy" The end date for this review is February 2022. Scientific novelty: This review aims to briefly review the problem of post-CPB bleeding in the pediatric population regarding multiple aspects. The medical literature lacks a comprehensive review regarding the problem of CHD, its prevalence, types, surgical options, post-cardiac surgery complications such as coagulopathy, the pathophysiology of the coagulopathy, and the preventive and therapeutic measures. The practical significance of the result obtained: This review may help surgeons and pediatricians deeply understand post-CPB coagulopathy's pathophysiology and how to anticipate, prevent, and manage it properly. Antifibrinolytic pharmaceuticals represent the mainstay for managing this problem; their administration during CPB reduces the risk of postoperative bleeding. Blood component transfusion is also an alternative option. Conclusion: Post-cardiac surgery, coagulopathy, and bleeding are major problems facing cardiothoracic surgeons. Postoperative bleeding, especially in the pediatric population, is one of the common causes of surgical re-exploration, leading to a higher risk of morbidities and mortalities. Meticulous preoperative examination, investigation, and intraoperative protective measures are important factors in avoiding and properly managing postoperative bleeding risk.
背景:先天性心脏病(CHD)是一种心脏或胸腔大血管的紊乱和异常，通常发生在胎儿发育期间。据报道，冠心病是一种常见的疾病。近25%的危重型冠心病新生儿在出生后一年内需要手术干预。因此，每年越来越多的体外循环(CPB)心脏手术通常与术后出血和凝血功能障碍有关。CPB后出血通常需要替代治疗，包括输注全血、红细胞、凝血因子或血小板。目的:确定心脏手术后凝血功能障碍的病理生理学，它如何影响临床结果，以及可用的管理选择。方法:在本综述中，我们只纳入了PubMed /MEDLINE、Web of Science、Scopus、Cochrane Library等常用电子数据库中以“先天性心脏病”、“心脏外科”为关键词并结合“凝血病变”相关关键词的英文文章，本综述结束日期为2022年2月。科学新颖性:本综述旨在从多个方面简要回顾小儿cpb后出血问题。医学文献缺乏关于冠心病的问题、患病率、类型、手术选择、心脏手术后并发症如凝血功能障碍、凝血功能障碍的病理生理学以及预防和治疗措施的全面综述。本研究结果的现实意义:本综述可以帮助外科医生和儿科医生深入了解cpb后凝血病的病理生理，以及如何正确预测、预防和管理它。抗纤溶药物是处理这一问题的主要药物;CPB期间给药可降低术后出血风险。输血也是另一种选择。结论:心脏手术后凝血功能障碍和出血是心胸外科医生面临的主要问题。术后出血，特别是在儿科人群中，是再次手术的常见原因之一，导致更高的发病率和死亡率。周密的术前检查、调查和术中保护措施是避免和妥善处理术后出血风险的重要因素。
{"title":"New research and changing paradigms of coagulopathy in children after cardiac surgery: A narrative review","authors":"","doi":"10.57125/fem.2022.03.25.03","DOIUrl":"https://doi.org/10.57125/fem.2022.03.25.03","url":null,"abstract":"Background: Congenital heart disease (CHD) is a disorder and abnormality of the heart or the great vessels of the thorax, which usually occurs during fetal development. It has been reported that CHD is a common condition. Nearly 25% of newborns with critical types of CHD require surgical intervention in the first year of life. Hence, increasing numbers of the annually conducted cardiopulmonary bypass (CPB) cardiac surgeries are usually associated with postoperative bleeding and coagulopathy. Bleeding after CPB usually requires a replacement therapy, including the transfusion of whole blood, red blood cells, coagulation factors, or platelets.\u0000\u0000Aim: to identify the pathophysiology of coagulopathy following cardiac surgery, how it impacts the clinical outcomes, and the available management options.\u0000\u0000Methods: In this review, we only included English articles from common electronic databases such as PubMed /MEDLINE, Web of Science, Scopus, and the Cochrane Library with the keywords \"congenital heart disease\", \"cardiac surgery\" combined with keywords involving \"coagulopathy\" The end date for this review is February 2022.\u0000\u0000Scientific novelty: This review aims to briefly review the problem of post-CPB bleeding in the pediatric population regarding multiple aspects. The medical literature lacks a comprehensive review regarding the problem of CHD, its prevalence, types, surgical options, post-cardiac surgery complications such as coagulopathy, the pathophysiology of the coagulopathy, and the preventive and therapeutic measures.\u0000\u0000The practical significance of the result obtained: This review may help surgeons and pediatricians deeply understand post-CPB coagulopathy's pathophysiology and how to anticipate, prevent, and manage it properly. Antifibrinolytic pharmaceuticals represent the mainstay for managing this problem; their administration during CPB reduces the risk of postoperative bleeding. Blood component transfusion is also an alternative option.\u0000\u0000Conclusion: Post-cardiac surgery, coagulopathy, and bleeding are major problems facing cardiothoracic surgeons. Postoperative bleeding, especially in the pediatric population, is one of the common causes of surgical re-exploration, leading to a higher risk of morbidities and mortalities. Meticulous preoperative examination, investigation, and intraoperative protective measures are important factors in avoiding and properly managing postoperative bleeding risk.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"210 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123578967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-30DOI: 10.57125/fem.2022.03.25.04
Background: Women frequently experience pelvic organ prolapse, significantly impacting their quality of life. Pelvic organ prolapse has a variety of treatment opportunities that should be used to each patient's needs, but the general rule is that only those exhibiting symptoms should receive care. Aim: to evaluate the treatment options for prolapse, depending on the type of prolapse and its degree. Methods: In this review, English studies from common databases such as Pubmed/MEDLINE, Web of science, Scopus, and the Cochrane Library with the keywords “pelvic organ prolapse,” “uterine prolapse,” “vaginal hysterectomy,” combined with keywords, involving “laparoscopic hysterectomy,” were involved. The end date for this review is February 2022. Scientific novelty: The main objective of this paper is to evaluate the treatment options for prolapse, depending on the type of prolapse and its degree. Even though many researchers assessed these treatment options, very few researchers reported about the treatment options according to the degree of prolapse. Many researchers compared surgical interventions for the management of pelvic organ prolapse. Though there are similar works, in the present study, the results of the surgical management depending on the severity of the prolapse were evaluated. The practical significance of the result obtained: The results may help physicians to determine the option of management depending on the degree of prolapse. First-degree (mild) usually does not require any treatment. Second-degree (moderate) may be treated with pessary, exercise, and surgery. Third-degree (severe) may be treated with pessary or surgery. Fourth-degree (complete) may be treated with vaginal hysterectomy, sacrocolpopexy, colpocleisis, and uterosacral ligament suspension. Conclusion: Depending on the surgeon's expertise, using various approaches, pelvic organ prolapse treatment is accomplished in various situations. All previous research indicate that surgery aims to maximise patient satisfaction and return the pelvic organs to their original positions.
背景:女性经常经历盆腔器官脱垂，严重影响她们的生活质量。盆腔器官脱垂有各种各样的治疗机会，应该用于每个病人的需要，但一般的规则是，只有那些表现出症状应该得到照顾。目的:根据脱垂的类型和程度，评价脱垂的治疗方案。方法:本综述纳入Pubmed/MEDLINE、Web of science、Scopus、Cochrane Library等常用数据库中以“盆腔器官脱垂”、“子宫脱垂”、“阴道子宫切除术”为关键词并结合“腹腔镜子宫切除术”的英文研究。本次审查的结束日期是2022年2月。科学新颖性:本文的主要目的是根据脱垂的类型和程度来评估脱垂的治疗选择。尽管许多研究人员评估了这些治疗方案，但很少有研究人员报道了根据脱垂程度的治疗方案。许多研究人员比较手术干预盆腔器官脱垂的管理。虽然有类似的工作，在本研究中，手术处理的结果取决于脱垂的严重程度进行了评估。结果的实际意义:结果可以帮助医生根据脱垂的程度决定管理的选择。一级(轻度)通常不需要任何治疗。二度(中度)可通过按摩、运动和手术治疗。三度(严重)可通过手术或手术治疗。四度(完全)可通过阴道子宫切除术、骶骶固定术、阴道闭锁术和子宫骶韧带悬吊术治疗。结论:根据外科医生的专业知识，采用不同的方法，盆腔器官脱垂的治疗可以在不同的情况下完成。所有先前的研究表明，手术的目的是最大限度地提高患者的满意度，并使盆腔器官恢复到原来的位置。
{"title":"Different treatment tactics of the pelvic organ prolapse according to the type and the degree of the prolapse: A narrative review","authors":"","doi":"10.57125/fem.2022.03.25.04","DOIUrl":"https://doi.org/10.57125/fem.2022.03.25.04","url":null,"abstract":"Background: Women frequently experience pelvic organ prolapse, significantly impacting their quality of life. Pelvic organ prolapse has a variety of treatment opportunities that should be used to each patient's needs, but the general rule is that only those exhibiting symptoms should receive care.\u0000\u0000Aim: to evaluate the treatment options for prolapse, depending on the type of prolapse and its degree.\u0000\u0000Methods: In this review, English studies from common databases such as Pubmed/MEDLINE, Web of science, Scopus, and the Cochrane Library with the keywords “pelvic organ prolapse,” “uterine prolapse,” “vaginal hysterectomy,” combined with keywords, involving “laparoscopic hysterectomy,” were involved. The end date for this review is February 2022.\u0000\u0000Scientific novelty: The main objective of this paper is to evaluate the treatment options for prolapse, depending on the type of prolapse and its degree. Even though many researchers assessed these treatment options, very few researchers reported about the treatment options according to the degree of prolapse. Many researchers compared surgical interventions for the management of pelvic organ prolapse. Though there are similar works, in the present study, the results of the surgical management depending on the severity of the prolapse were evaluated.\u0000\u0000The practical significance of the result obtained: The results may help physicians to determine the option of management depending on the degree of prolapse. First-degree (mild) usually does not require any treatment. Second-degree (moderate) may be treated with pessary, exercise, and surgery. Third-degree (severe) may be treated with pessary or surgery. Fourth-degree (complete) may be treated with vaginal hysterectomy, sacrocolpopexy, colpocleisis, and uterosacral ligament suspension.\u0000\u0000Conclusion: Depending on the surgeon's expertise, using various approaches, pelvic organ prolapse treatment is accomplished in various situations. All previous research indicate that surgery aims to maximise patient satisfaction and return the pelvic organs to their original positions.","PeriodicalId":327978,"journal":{"name":"Futurity Medicine","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128789879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：